UnitedHealth Group (UNH) Given New $280.00 Price Target at Barclays

UnitedHealth Group (NYSE:UNH) had its target price increased by stock analysts at Barclays from $265.00 to $280.00 in a report issued on Friday, Stock Target Advisor reports. The brokerage currently has an “overweight” rating on the healthcare conglomerate’s stock. Barclays’ target price suggests a potential upside of 7.85% from the stock’s current price.

A number of other brokerages have also recently commented on UNH. Citigroup cut UnitedHealth Group from a “buy” rating to a “neutral” rating and set a $288.00 price target for the company. in a research report on Monday, September 10th. Zacks Investment Research cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 18th. Raymond James upped their price target on UnitedHealth Group from $285.00 to $304.00 and gave the stock a “strong-buy” rating in a research report on Monday, September 24th. Morgan Stanley upped their price target on UnitedHealth Group from $278.00 to $305.00 and gave the stock an “overweight” rating in a research report on Wednesday, September 5th. Finally, ValuEngine cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, September 11th. One research analyst has rated the stock with a hold rating, twenty-two have given a buy rating and one has assigned a strong buy rating to the company. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus price target of $279.26.

UnitedHealth Group stock opened at $259.61 on Friday. The firm has a market cap of $256.06 billion, a P/E ratio of 25.78, a PEG ratio of 1.58 and a beta of 0.73. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.75 and a quick ratio of 0.75. UnitedHealth Group has a one year low of $186.00 and a one year high of $272.07.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 17th. The healthcare conglomerate reported $3.14 EPS for the quarter, beating analysts’ consensus estimates of $3.04 by $0.10. The company had revenue of $56.09 billion during the quarter, compared to analysts’ expectations of $56.10 billion. UnitedHealth Group had a return on equity of 22.79% and a net margin of 5.55%. UnitedHealth Group’s revenue for the quarter was up 12.1% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.46 earnings per share. As a group, research analysts anticipate that UnitedHealth Group will post 12.72 earnings per share for the current year.

In other news, EVP D Ellen Wilson sold 15,393 shares of the company’s stock in a transaction dated Friday, August 24th. The stock was sold at an average price of $264.29, for a total value of $4,068,215.97. Following the completion of the transaction, the executive vice president now owns 66,402 shares of the company’s stock, valued at $17,549,384.58. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Steven H. Nelson sold 26,033 shares of the company’s stock in a transaction dated Friday, September 7th. The stock was sold at an average price of $270.65, for a total value of $7,045,831.45. The disclosure for this sale can be found here. In the last ninety days, insiders sold 94,745 shares of company stock valued at $24,995,290. Corporate insiders own 0.87% of the company’s stock.

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Private Capital Advisors Inc. boosted its position in UnitedHealth Group by 9.2% during the 3rd quarter. Private Capital Advisors Inc. now owns 36,725 shares of the healthcare conglomerate’s stock valued at $7,193,000 after acquiring an additional 3,093 shares in the last quarter. Community Bank & Trust Waco Texas boosted its position in UnitedHealth Group by 1.7% during the 3rd quarter. Community Bank & Trust Waco Texas now owns 12,532 shares of the healthcare conglomerate’s stock valued at $3,334,000 after acquiring an additional 215 shares in the last quarter. Tower View Investment Management & Research LLC boosted its position in UnitedHealth Group by 8.1% during the 3rd quarter. Tower View Investment Management & Research LLC now owns 7,806 shares of the healthcare conglomerate’s stock valued at $2,077,000 after acquiring an additional 588 shares in the last quarter. Lau Associates LLC boosted its position in UnitedHealth Group by 2.1% during the 3rd quarter. Lau Associates LLC now owns 9,700 shares of the healthcare conglomerate’s stock valued at $2,581,000 after acquiring an additional 200 shares in the last quarter. Finally, Bank of Montreal Can boosted its position in UnitedHealth Group by 23.9% during the 3rd quarter. Bank of Montreal Can now owns 1,926,174 shares of the healthcare conglomerate’s stock valued at $512,441,000 after acquiring an additional 370,963 shares in the last quarter. 85.35% of the stock is owned by hedge funds and other institutional investors.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Read More: Price to Earnings Ratio (PE), For Valuing Stocks

Stock Target Advisor

Analyst Recommendations for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply